IMS Health Holdings Inc (IMS.N) Quote| Reuters.com
Edition:
United States

IMS Health Holdings Inc (IMS.N)

IMS.N on New York Stock Exchange

24.18USD
28 Jun 2016
Change (% chg)

$0.46 (+1.94%)
Prev Close
$23.72
Open
$23.88
Day's High
$24.20
Day's Low
$23.88
Volume
236,687
Avg. Vol
310,372
52-wk High
$33.42
52-wk Low
$22.37

IMS.N

Chart for IMS.N

About

IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organization... (more)

Overall

Beta: --
Market Cap(Mil.): $7,824.69
Shares Outstanding(Mil.): 329.88
Dividend: --
Yield (%): --

Financials

  IMS.N Industry Sector
P/E (TTM): 49.35 20.22 16.49
EPS (TTM): 0.48 -- --
ROI: 2.42 26.04 12.29
ROE: 9.35 27.55 10.22

Quintiles, IMS Health to merge in $9 billion deal

Contract medical research provider Transnational Holdings Inc will merge with healthcare information company IMS Health Holdings Inc in a deal worth about $9 billion. | Video

May 03 2016

BRIEF-IMS CEO says business model remains same for each of our companies, but we're going to make it better on each side"

* IMS CEO Ali says on con call: "the business model remains the same for each of our companies, but we're going to make it better on each side" Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

May 03 2016

U.S. prescription drug spending to hit $400 billion a year by 2020: IMS

U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

Apr 14 2016

U.S. prescription drug spending to hit $400 bln a year by 2020 -IMS

April 14 U.S. annual spending on prescription medicines will increase 22 percent over the next five years, climbing as high as $400 billion in 2020, according to a report released by health care information company IMS Health Holdings Inc on Thursday.

Apr 14 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.